Brevan Howard Capital Management’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.94M Sell
16,077
-43,988
-73% -$13.4M 0.05% 252
2026
Q1
$12.8M Buy
+60,065
New +$13.4M 0.11% 103
2025
Q4
Sell
-67,703
Closed -$9.07M 2081
2025
Q3
$9.07M Sell
67,703
-51,022
-43% -$5.4M 0.04% 130
2025
Q2
$11.6M Buy
118,725
+13,315
+13% +$1.06M 0.07% 154
2025
Q1
$7.66M Sell
105,410
-22,343
-17% -$1.76M 0.07% 77
2024
Q4
$9.23M Buy
+127,753
New +$9.69M 0.06% 78
2024
Q2
Sell
-22,480
Closed -$2.18M 1253
2024
Q1
$2.18M Buy
22,480
+16,370
+268% +$1.44M 0.02% 141
2023
Q4
$479K Buy
+6,110
New +$416K 0.01% 495

Other funds holding LRCX

Brevan Howard Capital Management's LRCX Position: Q2 2026 in Review

Brevan Howard Capital Management reduced its Lam Research (LRCX) stake by 73% in Q2 2026, selling an estimated $13.4M and leaving 16,077 shares worth $6.94M. The position accounts for 0.05% of the portfolio, ranked #252.

Brevan Howard Capital Management first reported a position in LRCX in Q4 2023 and has held it in 8 quarters since. The position peaked at $12.8M in Q1 2026. 3,114 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Brevan Howard Capital Management held 16,077 shares of Lam Research worth $6.94M as of Q2 2026.
  • Brevan Howard Capital Management sold 43,988 Lam Research shares in Q2 2026, an estimated $13.4M.
  • Lam Research made up 0.05% of Brevan Howard Capital Management's portfolio in Q2 2026, its #252 holding.
  • Brevan Howard Capital Management first reported a position in Lam Research in Q4 2023 and has held it in 8 quarters since.
  • Brevan Howard Capital Management's Lam Research position peaked at $12.8M in Q1 2026.
  • 3,114 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.